Corbus Pharmaceuticals Holdings, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €113.50M +171.5% -€131.80M -1.3% -116.1% +2.0 pp N/A N/A
    (estimated) €41.81M +741.5% -€133.49M +28.6% -319.3% +18 pp N/A N/A
    (estimated) €4.97M +8.1% -€103.83M +34.3% -2,089.8% -4.1 pp N/A N/A
    (estimated) €4.60M +219.2% -€77.34M +23.6% -1,682.2% +27 pp N/A N/A
    (estimated) €1.44M +∞% -€62.55M +80.4% -4,342.5% -43 pp N/A N/A
    €0.00 +NaN% -€34.68M -9.9% N/A -€36.05M +15.8% N/A
    €0.00 +NaN% -€38.47M -20.1% N/A -€31.14M -3.8% N/A
    €0.00 -100.0% -€48.16M +22.6% N/A -€32.37M -22.0% N/A
    €760.55K -77.6% -€39.29M -59.1% -5,166.4% -23 pp -€41.52M -51.5% -5,458.7% -29 pp
    €3.40M -89.1% -€96.01M +60.9% -2,827.0% -26 pp -€85.57M +130.8% -2,519.6% -24 pp
    €31.18M +649.5% -€59.65M +24.2% -191.3% +9.6 pp -€37.07M +54.8% -118.9% +4.6 pp
    €4.16M +97.6% -€48.02M +71.7% -1,154.5% +1.7 pp -€23.95M +2.5% -575.8% +5.3 pp
    €2.10M +27.7% -€27.97M +62.1% -1,328.6% -2.8 pp -€23.37M +104.9% -1,110.1% -4.2 pp
    €1.65M +194.8% -€17.25M +126.0% -1,046.3% +3.2 pp -€11.40M +191.6% -691.5% +0.077 pp
    €559.29K +∞% -€7.63M +248.4% -1,365.1% -14 pp -€3.91M +97.4% -699.2% -7.0 pp
    €0.00 +NaN% -€2.19M +321.8% N/A -€1.98M +526.3% N/A
    €0.00 +NaN% -€519.58K +67,811.7% N/A -€316.32K +47,542.1% N/A
    €0.00 -€765.08 N/A -€663.96 N/A

    Notifications